|
2026 Conference Publication Phase I clinical evaluation of allogeneic virus-specific T cell therapy in solid organ transplant recipients with refractory viral infectionsKhanna, Rajiv, Smith, Corey, Campbell, Scott, Hopkins, Peter, Chambers, Daniel, Holmes, Chen-Li, John, George, Francis, Ross, McKenzie, Scott and Neller, Michelle (2026). 391.2: Phase I clinical evaluation of allogeneic virus-specific T cell therapy in solid organ transplant recipients with refractory viral infections. Transplantation, 110 (9S). doi: 10.1097/01.tp.0001251460.06685.5d |
|
2026 Conference Publication Palivizumab in donor derived RSV infection in an adult bilateral lung transplant recipientMeharry, R.S., Vale, C., Winks, L., Vemuri, K., Tse, T., Carew, A., Chambers, D., Trotter, M., Fiene, A., Divithotawela, C., Bell, P., Zhang, L., Hopkins, P. and Mackintosh, J. (2026). Palivizumab in donor derived RSV infection in an adult bilateral lung transplant recipient. 46th Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) (ISHLT2026), Totonto, ON Canada, 22-26 April 2026. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2026.02.782 |
|
2026 Conference Publication The relationship between anti-ro antibodies, phenotype and outcomes in the Australasian Interstitial Lung Disease RegistryWatson, Stella, Hansen, Dylan, Glaspole, Ian, Glenn, Laura, Goh, Nicole, Mackintosh, John, Symons, Karen, Wilsher, Margaret, Wrobel, Jeremy, Chambers, Daniel, D'costa, Jason, De Boer, Sally, Edwards, Adrienne, Gabbay, Eli, Gallagher, Henry, Grainge, Christopher, Keir, Gregory, Kwan, Ben, Lim, K. P., Moodley, Yuben, Moore, Irene, Navaratnam, Vidya, Ong, Chong, Polasek, Jonathon, Reynolds, Paul, Teoh, Alan, Thien, Frank, Troy, Lauren, Veitch, Elizabeth ... Parker, Matthew J. S. (2026). THE RELATIONSHIP BETWEEN ANTI-RO ANTIBODIES, PHENOTYPE AND OUTCOMES IN THE AUSTRALASIAN INTERSTITIAL LUNG DISEASE REGISTRY. HOBOKEN: WILEY. |
|
2026 Conference Publication Deconvoluting fibrotic niches in idiopathic pulmonary fibrosis lungs using single-cell multiomicsCallen, Peter, Bartie, Caitlin, Tuzesi, Agota, Marx, Scarlett, McCloy, Rachael A., Sagi-Zsigmond, Eszter, Apte, Simon H., Tan, Maxine E., Chambers, Daniel C. and Powell, Joseph E. (2026). DECONVOLUTING FIBROTIC NICHES IN IDIOPATHIC PULMONARY FIBROSIS LUNGS USING SINGLE-CELL MULTIOMICS. HOBOKEN: WILEY. |
|
2026 Conference Publication Impact of the size of FVC decline on lung transplant-free survival among the Australasian Interstitial Lung Disease Registry (AILDR) patientsLi, Andrew, Stewart, Iain, Higginson, Emily, Buck, Evan, Teoh, Alan, Glenn, Laura, Troy, Lauren, Glaspole, Ian, Symons, Karen, Wilsher, Margaret, De Boer, Sally, Wrobel, Jeremy, Moodley, Yuben, Thien, Francis, Gallagher, Henry, Chambers, Daniel, Mackintosh, John, Goh, Nicole, Khor, Yet, Edwards, Adrienne, Grainge, Christopher, Kwan, Benjamin, Keir, Gregory, Ong, Chong, Reynolds, Paul, Veitch, Elizabeth, Gabbay, Eli, Pin, Lim Kuan, Polasek, Jonathon ... Corte, Tamera (2026). IMPACT OF THE SIZE OF FVC DECLINE ON LUNG TRANSPLANT-FREE SURVIVAL AMONG THE AUSTRALASIAN INTERSTITIAL LUNG DISEASE REGISTRY (AILDR) PATIENTS. HOBOKEN: WILEY. |
|
2026 Conference Publication AI interpretation of broncho-alveolar lavage cytology for personalised pulmonary fibrosis careHockey, Levi, Xiong, Zherui, Kaur, Ashandeep, Apte, Simon H., Groves, Penny L., Tan, Maxine E., Lutzky, Viviana P., Knuckley, Kiara, Zhang, Lai-Ying, Timmins, Sjane, Carew, Alan, Nguyen, Quan and Chambers, Daniel C. (2026). AI interpretation of broncho-alveolar lavage cytology for personalised pulmonary fibrosis care. Unknown, Unknown, Unknown. Richmond, VIC Australia: John Wiley & Sons. |
|
2026 Conference Publication Immunohistochemical expression within lung disease including carcinoma, with reference to cell lineage, the tumour microenvironment and elastin related proteinsDuhig, Edwina, van Zwieten, Anthony, Broomfield, Amy, Walsh, Michael, Lal, Sameeta, Godbolt, David, Davidson, Morgan, Mackintosh, John, Hopkins, Peter, Chambers, Daniel, Bowman, Rayleen, Fong, Kwun and Yang, Ian (2026). Immunohistochemical expression within lung disease including carcinoma, with reference to cell lineage, the tumour microenvironment and elastin related proteins. Pathology Update 2026, Sydney, NSW Australia, 6-8 March. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2026.01.049 |
|
2025 Conference Publication High Intensity Interval Training in Patients With Interstitial Lung DiseaseDowman, L., May, A., Hill, C.J., Bondarenko, J., Spencer, L., Morris, N., Alison, J.A., Walsh, J., Khor, Y.H., Goh, N.S.L., Corte, T.J., Glaspole, I., Chambers, D., McDonald, C. and Holland, A.E. (2025). High Intensity Interval Training in Patients With Interstitial Lung Disease. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a1038 |
|
2025 Conference Publication Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Sham-Controlled TrialHolland, A.E., Hoffman, M., Corte, T.J., Chambers, D., Palmer, A., Ekstrom, M.P., Glaspole, I., Goh, N. and McDonald, C.F. (2025). Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Sham-Controlled Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a2907 |
|
2025 Conference Publication Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical TrialMackintosh, J., Wells, J., Lutzky, V., Yerkovich, S.T., Yeh, R., Hsu, A., Pickett, H., Pietsch, M., Cooper, B., Enever, D., Bancroft, S., Apte, S., Tan, M., Dickinson, J., Lucas, S., Selvadurai, H., Grainge, C., Hopkins, P., Glaspole, I., Reynolds, P.N., Wrobel, J.P., Goh, N., Corte, T.J. and Chambers, D. (2025). Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a1010 |
|
2025 Conference Publication Iron alters the transcriptome and volatile organic compounds in the BAL of silicosis patientsAloe, C., Goh, N., Wang, H., McQualter, J., Doomun, S., De Souza, D., Pujari, R., Papagianis, P., Apte, S., Barnes, H., Vlahos, R., McDonald, C., Hoy, R., Chambers, D., Leong, T. and Bozinovski, S. (2025). IRON ALTERS THE TRANSCRIPTOME AND VOLATILE ORGANIC COMPOUNDS IN THE BAL OF SILICOSIS PATIENTS. HOBOKEN: WILEY. |
|
2024 Conference Publication Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary FibrosisZhang, L.-Y., Apte, S., Lutzky, V., Groves, P., Tan, M., de Silva, T.A., Nguyen, Q., Powell, J., Chambers, D. and O'Sullivan, B. (2024). Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary Fibrosis. American Thoracic Society 2024 International Conference, San Diego, CA United States, 17-22 May 2024. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2580 |
|
2023 Conference Publication Late Breaking Abstract - Transcriptomic profiling identifies pro-fibrotic macrophages under ferroptotic stress in silicosisAloe, Christian, Goh, Nicole Soo Leng, Mcqualter, Jonathan, Pujari, Reshma, Cameron, Rhoda, Teague, Julie, Papagianis, Paris, Apte, Simon Hall, O'Sullivan, Brendan, Vlahos, Ross, Mcdonald, Christine Faye, Hoy, Ryan Francis, Chambers, Daniel Charles, Leong, Tracy Li-Tsein and Bozinovski, Steven (2023). Late Breaking Abstract - Transcriptomic profiling identifies pro-fibrotic macrophages under ferroptotic stress in silicosis. Annual Congress of the European-Respiratory-Society (ERS), Milan Ia, Sep 09-13, 2023. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2023.PA2233 |
|
2023 Conference Publication Safety and efficacy study of ACT001 in IPF and fILD patientsGlaspole, Ian, Cai, Dongpo and Chambers, Dan (2023). Safety and efficacy study of ACT001 in IPF and fILD patients. Annual Congress of the European-Respiratory-Society (ERS), Milan Ia, Sep 09-13, 2023. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2023.OA2585 |
|
2022 Conference Publication Clinical Utility of a Standardized HP Exposure QuestionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T. J., Bastiampillai, S. A., Frenkel, S., Westall, G., Collard, H. R. and Glaspole, I. (2022). Clinical Utility of a Standardized HP Exposure Questionnaire. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2022. NEW YORK: AMER THORACIC SOC. |
|
2022 Conference Publication Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - progress during the pandemicMoore, I., Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, I., Grainge, C., Wilsher, M. L., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. J. (2022). Australia and New Zealand Interstitial Lung Disease Registry (ANZ ILD) 2021 Update - Progress During the Pandemic. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2022. NEW YORK: AMER THORACIC SOC. |
|
2022 Conference Publication Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update - Progress during the pandemicMoore, , Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, , Grainge, C., Wilsher, M., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. (2022). Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemic. HOBOKEN: WILEY. |
|
2022 Conference Publication Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national populationChee, M., Corte, T., Jackson, D., Lee, C., Wrobel, J., Glaspole, , Grainge, C., Wilsher, M., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Thien, F. (2022). Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national population. HOBOKEN: WILEY. |
|
2022 Conference Publication Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T., Bastiampillai, S., Frenkel, S., Westall, G., Collard, H. and Glaspole, (2022). Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaire. HOBOKEN: WILEY. |
|
2022 Conference Publication Polygenic risk scores in familial IPF implicates rare variantsLucas, S., Raspin, K., Chambers, D., Glaspole, , Reynolds, P., Schwartz, D., Walters, H., Wood-Baker, R., Walsh, S., Moodley, Y., Corte, T. and Dickinson, J. (2022). Polygenic risk scores in familial IPF implicates rare variants. HOBOKEN: WILEY. |
